- Home
- FLNT vs CING Comparison
FLNT vs CING Comparison
Compare FLNT & CING Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FLNT | CING |
|---|---|---|
| Founded | 2010 | 2012 |
| Country | United States | United States |
| Employees | N/A | 13 |
| Industry | Advertising | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 108.5M | 93.1M |
| IPO Year | 2009 | N/A |
Fundamental Metrics
Financial Performance| Metric | FLNT | CING |
|---|---|---|
| Price | $3.48 | $5.26 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | $3.50 | ★ $34.50 |
| AVG Volume (30 Days) | 29.5K | ★ 542.3K |
| Earning Date | 05-14-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 41.67 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $208,764,000.00 | N/A |
| Revenue This Year | $5.89 | N/A |
| Revenue Next Year | $12.62 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.50 | $3.20 |
| 52 Week High | $4.15 | $11.89 |
Technical Indicators
Market Signals| Indicator | FLNT | CING |
|---|---|---|
| Relative Strength Index (RSI) | 54.24 | 37.27 |
| Support Level | $2.93 | $3.58 |
| Resistance Level | $3.57 | $6.85 |
| Average True Range (ATR) | 0.23 | 0.51 |
| MACD | 0.01 | -0.13 |
| Stochastic Oscillator | 79.83 | 8.04 |
Price Performance
Historical ComparisonAbout FLNT Fluent Inc.
Fluent Inc is a data-driven digital marketing services company. It performs customer acquisition services by operating digital marketing campaigns, through which it connects its advertiser clients with consumers company is seeking to reach. It delivers data and performance-based marketing executions to its clients, such as consumer brands, direct marketers and agencies across a wide range of industries, including Financial Products & Services, Media & Entertainment, Health & Wellness, Staffing & Recruitment and Retail & Consumer.
About CING Cingulate Inc.
Cingulate Inc is a clinical-stage biopharmaceutical company utilizing its proprietary precision timed-release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic area to use PTR technology to develop future product candidates.